Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BioChaperone Insulin Lispro vs Humalog in T1DM
NCT02528396Phase 1Completed
- Sponsor
- Adocia
- Start
- Aug 2015
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of insulin lispro in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Adocia. Primary endpoints: Area Under the Curve of Postprandial Glucose Excursion 0-2 hours and Area Under the Curve of Insulin Lispro 0-30 minutes. Started Aug 2015; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02528396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02528396.